Literature DB >> 8093808

Multiple sclerosis is associated with genes within or close to the HLA-DR-DQ subregion on a normal DR15,DQ6,Dw2 haplotype.

J Hillert1, O Olerup.   

Abstract

The HLA class II haplotype DR15,DQ6,Dw2 is associated with an increased risk for multiple sclerosis (MS). It has previously been shown that this haplotype extends to the HLA-DQA2 locus but not to the HLA-DP subregion. We report the distribution in 148 MS patients and 158 healthy controls of Taq I restriction fragments of the C4, cytochrome P-21 (CYP21), and HLA-B genes. Approximately 90% of the DR15,DQ6,Dw2 haplotypes extend to the C4/CYP21 loci and 50% to the HLA-B locus, indicated by a significant association of the haplotype with restriction fragments of these loci. However, there was no independent association in MS patients with these genes. This indicates that the susceptibility to MS is coded for by genes within or close to the HLA-DR-DQ subregion. Furthermore, the delineation of the DR15,DQ6,Dw2 haplotype is very similar in MS patients and control subjects. This observation supports the hypothesis that "normal" genes, common to all carriers of the DR15,DQ6,Dw2 haplotype, confer the increased genetic susceptibility to MS associated with this haplotype.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8093808     DOI: 10.1212/wnl.43.1_part_1.163

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  15 in total

1.  The presence of glutamic acid at positions 71 or 74 in pocket 4 of the HLA-DRbeta1 chain is associated with the clinical course of multiple sclerosis.

Authors:  J M Greer; M P Pender
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-05       Impact factor: 10.154

2.  Definition of a 1.06-Mb region linked to neuroinflammation in humans, rats and mice.

Authors:  Johan Ockinger; Pablo Serrano-Fernández; Steffen Möller; Saleh M Ibrahim; Tomas Olsson; Maja Jagodic
Journal:  Genetics       Date:  2006-04-19       Impact factor: 4.562

3.  Analysis of extended HLA haplotypes in multiple sclerosis and narcolepsy families confirms a predisposing effect for the class I region in Tasmanian MS patients.

Authors:  Justin P Rubio; Melanie Bahlo; Jim Stankovich; Rachel K Burfoot; Laura J Johnson; Stewart Huxtable; Helmut Butzkueven; Ling Lin; Bruce V Taylor; Terence P Speed; Trevor J Kilpatrick; Emmanuel Mignot; Simon J Foote
Journal:  Immunogenetics       Date:  2007-01-26       Impact factor: 2.846

Review 4.  Of the multiple mechanisms leading to type 1 diabetes, T cell receptor revision may play a prominent role (is type 1 diabetes more than a single disease?).

Authors:  D H Wagner
Journal:  Clin Exp Immunol       Date:  2016-07-25       Impact factor: 4.330

5.  Multiple sclerosis in Sardinia is associated and in linkage disequilibrium with HLA-DR3 and -DR4 alleles.

Authors:  M G Marrosu; M R Murru; G Costa; F Cucca; S Sotgiu; G Rosati; F Muntoni
Journal:  Am J Hum Genet       Date:  1997-08       Impact factor: 11.025

6.  Analysis of allelic association between D6S461 marker and multiple sclerosis in Ashkenazi and Iraqi Jewish patients.

Authors:  Y Shinar; E Pras; I Siev-Ner; D Gamus; C Brautbar; S Israel; A Achiron
Journal:  J Mol Neurosci       Date:  1998-12       Impact factor: 3.444

7.  Genetic dissection of the human leukocyte antigen region by use of haplotypes of Tasmanians with multiple sclerosis.

Authors:  Justin P Rubio; Melanie Bahlo; Helmut Butzkueven; Ingrid A F van Der Mei; Michèle M Sale; Joanne L Dickinson; Patricia Groom; Laura J Johnson; Rex D Simmons; Brian Tait; Mike Varney; Bruce Taylor; Terence Dwyer; Robert Williamson; Nicholas M Gough; Trevor J Kilpatrick; Terence P Speed; Simon J Foote
Journal:  Am J Hum Genet       Date:  2002-03-29       Impact factor: 11.025

8.  Is there a place for 'immuno' in the immunotherapy of multiple sclerosis?

Authors:  Thomas G Forsthuber; Paolo Muraro
Journal:  Immunotherapy       Date:  2009-05       Impact factor: 4.196

9.  Fine-mapping resolves Eae23 into two QTLs and implicates ZEB1 as a candidate gene regulating experimental neuroinflammation in rat.

Authors:  Pernilla Stridh; Melanie Thessen Hedreul; Amennai Daniel Beyeen; Milena Z Adzemovic; Hannes Laaksonen; Alan Gillett; Johan Ockinger; Monica Marta; Hans Lassmann; Kristina Becanovic; Maja Jagodic; Tomas Olsson
Journal:  PLoS One       Date:  2010-09-15       Impact factor: 3.240

10.  HLA class II alleles in patients with multiple sclerosis in the Biscay province (Basque Country, Spain).

Authors:  Oscar Fernández; Alfredo R-Antigüedad; María Jesús Pinto-Medel; Mari Mar Mendibe; Nestor Acosta; Begoña Oliver; Miguel Guerrero; Marcos Papais-Alvarenga; Victoria Fernández-Sánchez; Laura Leyva
Journal:  J Neurol       Date:  2009-12       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.